The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates
Belinda E Kiely, Andrew J Martin, Martin HN Tattersall, Anna K Nowak, David Goldstein, Nicholas RC Wilcken, David K Wyld, Ehtesham A Abdi, Amanda Glasgow, Philip J Beale, Michael Jefford, Paul A Glare, Martin R Stockler
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2013
B.E.K. was supported by a National Breast Cancer Foundation PhD Scholarship, a Cancer Institute NSW Research Scholar Award, and a National Health and Medical Research Council (NHMRC) Australia Program Grant. The ZEST Trial was supported by grants from the Cancer Councils of New South Wales and South Australia, the NHMRC of Australia, Pfizer Australia, Pfizer International, and the Clinical Trials Partnership of the Cancer Institute New South Wales and the NHMRC Clinical Trials Centre.